NFLD Northfield Laboratories Inc. (MM)

EVANSTON, Ill., Nov. 2 /PRNewswire-FirstCall/ -- Northfield Laboratories Inc. (NASDAQ:NFLD) announced today that Steven A. Gould, M.D., Chairman and Chief Executive Officer, will be presenting at the SG Cowen & Company Global Health Care Conference in Barcelona, Spain, on Wednesday, November 9, 2005, at 8:35 a.m. local time, 2:35 a.m. E.T. Interested investors may access the live webcast of the presentation at http://www.northfieldlabs.com/ . A replay of the presentation will be available and will be archived for two weeks. About Northfield Laboratories Northfield Laboratories Inc. is a leader in developing an oxygen-carrying resuscitative fluid, PolyHeme(R), for the treatment of urgent, large volume blood loss in trauma and resultant surgical settings. PolyHeme(R) is a solution of chemically modified human hemoglobin that requires no cross matching and is therefore compatible with all blood types. It has a shelf life of over 12 months. Enrollment is currently underway in a pivotal Phase III trial of PolyHeme(R) beginning in the pre-hospital setting. For further information, visit http://www.northfieldlabs.com/ . FOR FURTHER INFORMATION CONTACT: Sharon L. Weinstein Sophia H. Twaddell Director, Investor Relations Vice President, Corporate Communications Noonan Russo (847) 864-3500 (212) 845-4271 DATASOURCE: Northfield Laboratories Inc. CONTACT: Sophia H. Twaddell, Vice President, Corporate Communications, of Northfield Laboratories Inc., +1-847-864-3500, ; or Sharon L. Weinstein, Director, Investor Relations, of Noonan Russo, +1-212-845-4271, Web site: http://www.northfieldlabs.com/

Copyright